XERS (xerispharma.com) Earnings per share growth this year

Official company branding of Xeris Pharma (XERS)

Xeris Biopharma dominates emergency medicine due to inelastic demand for life-saving treatments. The annual earnings per share growth indicator demonstrates capital dynamics, with the metric holding at -660.20. The company mitigates the risks of a narrow endocrinology product portfolio through technology licensing. The innovative XeriSol platform enables the sale of ready-to-use injections with a premium markup for ease of use.

XERS (xerispharma.com) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for xerispharma.com (XERS)

- stock value and consensus price forecast:
Basic company analysis:Xeris Pharma (XERS)
Manufactured products of Xeris Biopharma

For Xeris Biopharma (XERS), which is scaling sales of innovative injectable drugs based on XeriSol and XeriLect, the annual volatility of earnings per share serves as an indicator of product commercialization efficiency. This metric calculates the percentage deviation of current net income per share from the value of the same period last year, allowing investors to verify the business profitability recovery trend in real-time.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year KROS (Keros Therapeutics)|ARCT: Earnings growth in current year|Eton Pharmaceuticals Inc (ETON) - Earnings growth in current year|Earnings per share growth in current year Kamada Corp|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc